Testicular relapse of AML during chronic graft-versus-host disease induced by donor leukocyte infusion

Haematologica

Volumn 81, Issue 4, 1996, Pages 339-342

  Tringali, Stefania ^a   Vasta, Stefania ^a   Scimè, Rosanna ^a   Catania, Patrizia ^a   Cavallaro, Anna Maria ^a   Majolino, Ignazio ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

AML; Donor leukocyte infusion; GVHD; GVL; Testis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CASE REPORT; GRAFT VERSUS HOST REACTION; HUMAN; LEUKOCYTE; MALE; RELAPSE; STEM CELL TRANSPLANTATION;

ADULT; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTE TRANSFUSION; MALE; TESTICULAR NEOPLASMS;

EID: 0030323733     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Odom IF, August CS, Githens JH, et al. Remission of relapsed leukemia during a graft-versus-host reaction: a graft-versus-host reaction in man? Lancet 1978; ii:537-40.
2. Porter DL, Roth MS, Mc Garigle C, Ferrara JLM, Antin JH. Induction of a graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330:100-6.
3. Szer J, Grigg AP, Phillips GL, Sheridan WP. Donor leucocyte infusion after chemotherapy for patients relapsing with acute leukemia following allogeneic BMT. Bone Marrow Transplant 1993; 11:109-11.
4. Ferster A, Bujan W, Moureaux T, Devalk Ch, Heimann P, Sariban E. Complete remission following donor leucocyte infusion in All relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplant 1994; 14:331-2.
5. Goldberg SI. Lack of a graft-versus-leukemia effect in an immunologically privileged sanctuary site (letter). Bone Marrow Transplant 1994; 12:180-1
6. Majolino I, Aversa F, Bacigalupo A, Bandini G, Arcese W, Reali G for GITMO. Allogeneic transplants of rhG-CSF mobilized peripheral blood stem cell from normal donors. Haematologica 1995; 80:40-3.
7. Majolino I, Buscemi F, Seimè R, et al. Treatment of normal donors with rhG-CSF 16 μg/kg for mobilization of peripheral blood stem cell and their apheretic collection in view of allogeneic transplantation. Haematologica 1995; 80:219-26.
8. Giralt S, Escudier S, Kantarijan H, et al. Preliminary results of treatment with filgrastim for relapse of leukemia and myelodisplasia after allogeneic bone marrow transplantation. N Engl J Med 1993; 329:757-61.
9. Kolb HJ, Mittermuller J, Clemm CH, et al. Donor leukocyte transfusion for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76:2462-75.
10. Sullivan KM, Storb R, Bucner CD, et al. Graft-versus-host as adoptive immunotherapy in patients with advanced hematologie neoplasm. N Engl J Med 1989; 320:828-34.
11. Rouah E, Gruber R, Shearer W, Armstrong D, Hawkins E. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol 1988; 89:543-6.
12. Marosi C, Budka H Grimm G, et al. Fatal encephalitis in a patient with chronic graft-versus-host disease. Bone Marrow Transplant 1990; 6:53-7.